Ellen Kapiteijn

Ellen Kapiteijn

Department of Medical Oncology, Leiden University Medical Centre

Affiliated withLeiden University Medical Centre

Research Area

Biography

Ellen Kapiteijn has not added Biography.
If you are Ellen Kapiteijn and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Publication title

Cited by 12

2016

Other Publications

Article
Year
p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.

International journal of radiation oncology, biology, physics| PubMed ID: 11849795

2002
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 11919228

2002
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.

European journal of endocrinology / European Federation of Endocrine Societies| PubMed ID: 19773371

2009
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.

The Journal of clinical endocrinology and metabolism| PubMed ID: 20484486

2010
2011
Severe colitis while responding to ipilimumab in metastatic melanoma.

Acta oncologica (Stockholm, Sweden)| PubMed ID: 22551308

2012
2012
2013
2013
2013
2013
2014
2014
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

Science translational medicine| PubMed ID: 25232180

2014
2015
2015
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.

Cardiovascular and interventional radiology| PubMed ID: 26718962

2015
2016
2016
2016
2016